Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Heparin Sodium Injection Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Heparin Sodium Injection Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Heparin Sodium Injection Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Heparin Sodium Injection Market Size Growth Rate by Type
    • 1.4.2 1,000 USP Units / mL
    • 1.4.3 5,000 USP Units / mL
    • 1.4.4 10,000 USP Units / mL
  • 1.5 Market by Application
    • 1.5.1 Global Heparin Sodium Injection Market Size Growth Rate by Application
    • 1.5.2 Treatment of Venous Thromboembolism
    • 1.5.3 Complications of Pregnancy
    • 1.5.4 Cardioversion of Atrial Fibrillation/Flutter
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Heparin Sodium Injection Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Heparin Sodium Injection Industry
      • 1.6.1.1 Heparin Sodium Injection Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Heparin Sodium Injection Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Heparin Sodium Injection Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Heparin Sodium Injection Market Size Estimates and Forecasts
    • 2.1.1 Global Heparin Sodium Injection Revenue 2015-2026
    • 2.1.2 Global Heparin Sodium Injection Sales 2015-2026
  • 2.2 Heparin Sodium Injection Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Heparin Sodium Injection Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Heparin Sodium Injection Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Heparin Sodium Injection Competitor Landscape by Players

  • 3.1 Heparin Sodium Injection Sales by Manufacturers
    • 3.1.1 Heparin Sodium Injection Sales by Manufacturers (2015-2020)
    • 3.1.2 Heparin Sodium Injection Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Heparin Sodium Injection Revenue by Manufacturers
    • 3.2.1 Heparin Sodium Injection Revenue by Manufacturers (2015-2020)
    • 3.2.2 Heparin Sodium Injection Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Heparin Sodium Injection Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Heparin Sodium Injection Revenue in 2019
    • 3.2.5 Global Heparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Heparin Sodium Injection Price by Manufacturers
  • 3.4 Heparin Sodium Injection Manufacturing Base Distribution, Product Types
    • 3.4.1 Heparin Sodium Injection Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Heparin Sodium Injection Product Type
    • 3.4.3 Date of International Manufacturers Enter into Heparin Sodium Injection Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Heparin Sodium Injection Market Size by Type (2015-2020)
    • 4.1.1 Global Heparin Sodium Injection Sales by Type (2015-2020)
    • 4.1.2 Global Heparin Sodium Injection Revenue by Type (2015-2020)
    • 4.1.3 Heparin Sodium Injection Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Heparin Sodium Injection Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Heparin Sodium Injection Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Heparin Sodium Injection Revenue Forecast by Type (2021-2026)
    • 4.2.3 Heparin Sodium Injection Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Heparin Sodium Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Heparin Sodium Injection Market Size by Application (2015-2020)
    • 5.1.1 Global Heparin Sodium Injection Sales by Application (2015-2020)
    • 5.1.2 Global Heparin Sodium Injection Revenue by Application (2015-2020)
    • 5.1.3 Heparin Sodium Injection Price by Application (2015-2020)
  • 5.2 Heparin Sodium Injection Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Heparin Sodium Injection Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Heparin Sodium Injection Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Heparin Sodium Injection Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Heparin Sodium Injection by Country
    • 6.1.1 North America Heparin Sodium Injection Sales by Country
    • 6.1.2 North America Heparin Sodium Injection Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Heparin Sodium Injection Market Facts & Figures by Type
  • 6.3 North America Heparin Sodium Injection Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Heparin Sodium Injection by Country
    • 7.1.1 Europe Heparin Sodium Injection Sales by Country
    • 7.1.2 Europe Heparin Sodium Injection Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Heparin Sodium Injection Market Facts & Figures by Type
  • 7.3 Europe Heparin Sodium Injection Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Heparin Sodium Injection by Region
    • 8.1.1 Asia Pacific Heparin Sodium Injection Sales by Region
    • 8.1.2 Asia Pacific Heparin Sodium Injection Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Heparin Sodium Injection Market Facts & Figures by Type
  • 8.3 Asia Pacific Heparin Sodium Injection Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Heparin Sodium Injection by Country
    • 9.1.1 Latin America Heparin Sodium Injection Sales by Country
    • 9.1.2 Latin America Heparin Sodium Injection Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Heparin Sodium Injection Market Facts & Figures by Type
  • 9.3 Central & South America Heparin Sodium Injection Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Heparin Sodium Injection by Country
    • 10.1.1 Middle East and Africa Heparin Sodium Injection Sales by Country
    • 10.1.2 Middle East and Africa Heparin Sodium Injection Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Heparin Sodium Injection Market Facts & Figures by Type
  • 10.3 Middle East and Africa Heparin Sodium Injection Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Shenzhen Hepalink
    • 11.1.1 Shenzhen Hepalink Corporation Information
    • 11.1.2 Shenzhen Hepalink Description, Business Overview and Total Revenue
    • 11.1.3 Shenzhen Hepalink Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Shenzhen Hepalink Heparin Sodium Injection Products Offered
    • 11.1.5 Shenzhen Hepalink Recent Development
  • 11.2 Bioibérica
    • 11.2.1 Bioibérica Corporation Information
    • 11.2.2 Bioibérica Description, Business Overview and Total Revenue
    • 11.2.3 Bioibérica Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bioibérica Heparin Sodium Injection Products Offered
    • 11.2.5 Bioibérica Recent Development
  • 11.3 Nanjing King-friend
    • 11.3.1 Nanjing King-friend Corporation Information
    • 11.3.2 Nanjing King-friend Description, Business Overview and Total Revenue
    • 11.3.3 Nanjing King-friend Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Nanjing King-friend Heparin Sodium Injection Products Offered
    • 11.3.5 Nanjing King-friend Recent Development
  • 11.4 Pfizer
    • 11.4.1 Pfizer Corporation Information
    • 11.4.2 Pfizer Description, Business Overview and Total Revenue
    • 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer Heparin Sodium Injection Products Offered
    • 11.4.5 Pfizer Recent Development
  • 11.5 Dongcheng Biochemicals
    • 11.5.1 Dongcheng Biochemicals Corporation Information
    • 11.5.2 Dongcheng Biochemicals Description, Business Overview and Total Revenue
    • 11.5.3 Dongcheng Biochemicals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Dongcheng Biochemicals Heparin Sodium Injection Products Offered
    • 11.5.5 Dongcheng Biochemicals Recent Development
  • 11.6 Changzhou Qianhong Bio-pharma
    • 11.6.1 Changzhou Qianhong Bio-pharma Corporation Information
    • 11.6.2 Changzhou Qianhong Bio-pharma Description, Business Overview and Total Revenue
    • 11.6.3 Changzhou Qianhong Bio-pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Products Offered
    • 11.6.5 Changzhou Qianhong Bio-pharma Recent Development
  • 11.7 Changshan Biochemical
    • 11.7.1 Changshan Biochemical Corporation Information
    • 11.7.2 Changshan Biochemical Description, Business Overview and Total Revenue
    • 11.7.3 Changshan Biochemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Changshan Biochemical Heparin Sodium Injection Products Offered
    • 11.7.5 Changshan Biochemical Recent Development
  • 11.8 Pharma Action
    • 11.8.1 Pharma Action Corporation Information
    • 11.8.2 Pharma Action Description, Business Overview and Total Revenue
    • 11.8.3 Pharma Action Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Pharma Action Heparin Sodium Injection Products Offered
    • 11.8.5 Pharma Action Recent Development
  • 11.9 Baxter
    • 11.9.1 Baxter Corporation Information
    • 11.9.2 Baxter Description, Business Overview and Total Revenue
    • 11.9.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Baxter Heparin Sodium Injection Products Offered
    • 11.9.5 Baxter Recent Development
  • 11.10 Dongying Tiandong Pharmaceutical
    • 11.10.1 Dongying Tiandong Pharmaceutical Corporation Information
    • 11.10.2 Dongying Tiandong Pharmaceutical Description, Business Overview and Total Revenue
    • 11.10.3 Dongying Tiandong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Products Offered
    • 11.10.5 Dongying Tiandong Pharmaceutical Recent Development
  • 11.1 Shenzhen Hepalink
    • 11.1.1 Shenzhen Hepalink Corporation Information
    • 11.1.2 Shenzhen Hepalink Description, Business Overview and Total Revenue
    • 11.1.3 Shenzhen Hepalink Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Shenzhen Hepalink Heparin Sodium Injection Products Offered
    • 11.1.5 Shenzhen Hepalink Recent Development
  • 11.12 Aspen Oss
    • 11.12.1 Aspen Oss Corporation Information
    • 11.12.2 Aspen Oss Description, Business Overview and Total Revenue
    • 11.12.3 Aspen Oss Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Aspen Oss Products Offered
    • 11.12.5 Aspen Oss Recent Development
  • 11.13 Xinbai Pharmaceuticals
    • 11.13.1 Xinbai Pharmaceuticals Corporation Information
    • 11.13.2 Xinbai Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.13.3 Xinbai Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Xinbai Pharmaceuticals Products Offered
    • 11.13.5 Xinbai Pharmaceuticals Recent Development
  • 11.14 Yino Pharma Limited
    • 11.14.1 Yino Pharma Limited Corporation Information
    • 11.14.2 Yino Pharma Limited Description, Business Overview and Total Revenue
    • 11.14.3 Yino Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Yino Pharma Limited Products Offered
    • 11.14.5 Yino Pharma Limited Recent Development
  • 11.15 Sichuan Deebio
    • 11.15.1 Sichuan Deebio Corporation Information
    • 11.15.2 Sichuan Deebio Description, Business Overview and Total Revenue
    • 11.15.3 Sichuan Deebio Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Sichuan Deebio Products Offered
    • 11.15.5 Sichuan Deebio Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Heparin Sodium Injection Market Estimates and Projections by Region
    • 12.1.1 Global Heparin Sodium Injection Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Heparin Sodium Injection Revenue Forecast by Regions 2021-2026
  • 12.2 North America Heparin Sodium Injection Market Size Forecast (2021-2026)
    • 12.2.1 North America: Heparin Sodium Injection Sales Forecast (2021-2026)
    • 12.2.2 North America: Heparin Sodium Injection Revenue Forecast (2021-2026)
    • 12.2.3 North America: Heparin Sodium Injection Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Heparin Sodium Injection Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Heparin Sodium Injection Sales Forecast (2021-2026)
    • 12.3.2 Europe: Heparin Sodium Injection Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Heparin Sodium Injection Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Heparin Sodium Injection Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Heparin Sodium Injection Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Heparin Sodium Injection Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Heparin Sodium Injection Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Heparin Sodium Injection Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Heparin Sodium Injection Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Heparin Sodium Injection Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Heparin Sodium Injection Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Heparin Sodium Injection Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Heparin Sodium Injection Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Heparin Sodium Injection Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Heparin Sodium Injection Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Heparin Sodium Injection Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Heparin Sodium Injection Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Heparin Sodium Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Heparin Sodium Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Heparin Sodium Injection market is segmented into
    1,000 USP Units / mL
    5,000 USP Units / mL
    10,000 USP Units / mL

    Segment by Application, the Heparin Sodium Injection market is segmented into
    Treatment of Venous Thromboembolism
    Complications of Pregnancy
    Cardioversion of Atrial Fibrillation/Flutter
    Other

    Regional and Country-level Analysis
    The Heparin Sodium Injection market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Heparin Sodium Injection market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Heparin Sodium Injection Market Share Analysis
    Heparin Sodium Injection market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Heparin Sodium Injection business, the date to enter into the Heparin Sodium Injection market, Heparin Sodium Injection product introduction, recent developments, etc.
    The major vendors covered:
    Shenzhen Hepalink
    Bioibérica
    Nanjing King-friend
    Pfizer
    Dongcheng Biochemicals
    Changzhou Qianhong Bio-pharma
    Changshan Biochemical
    Pharma Action
    Baxter
    Dongying Tiandong Pharmaceutical
    Opocrin
    Aspen Oss
    Xinbai Pharmaceuticals
    Yino Pharma Limited
    Sichuan Deebio

    Buy now